Axillo-axillary bypass with polytetrafluoroethylene graft for coronary subclavian steal syndrome

Vascular. 2012 Aug;20(4):188-92. doi: 10.1258/vasc.2011.oa0344. Epub 2012 Jun 11.

Abstract

The purpose of this study is to report the results of axillo-axillary bypass (AAB) for coronary subclavian steal syndrome due to proximal subclavian artery occlusion. From 2003 to 2010, AAB using a polytetrafluoroethylene (PTFE) graft was performed in 11 patients with coronary subclavian steal syndrome. There was no perioperative mortality, stroke or cardiac complications. Over a mean follow-up of 36 months (range: 6-81 months), all bypass grafts have remained patent. No patient developed recurrent symptoms of myocardial ischemia. One patient died from hemorrhagic stroke at 31 months. Our results showed that AAB using a PTFE graft provides an effective and durable treatment option for coronary subclavian steal syndrome when attempted endovascular therapy of the occluded proximal subclavian artery is unsuccessful.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Axillary Artery / surgery*
  • Blood Vessel Prosthesis Implantation / adverse effects
  • Blood Vessel Prosthesis Implantation / instrumentation*
  • Blood Vessel Prosthesis*
  • China
  • Coronary-Subclavian Steal Syndrome / physiopathology
  • Coronary-Subclavian Steal Syndrome / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Polytetrafluoroethylene*
  • Prosthesis Design
  • Retrospective Studies
  • Subclavian Artery / surgery*
  • Time Factors
  • Treatment Outcome
  • Vascular Patency

Substances

  • Polytetrafluoroethylene